微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.58% | -18.65% | 94.89% | 18/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 2.35% | -40.95% | 35.84% | 25/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.73% | -19.53% | -72.93% | 14/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 6.39% | -39.32% | 13.5% | 20/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 5.63% | -43.3% | 41.46% | 24/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 3.98% | -33.89% | 85.12% | 21/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.15% | -25.09% | -79.58% | 19/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 10.53% | -2.77% | 6.04% | 20/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 9.93% | -52.17% | 64.95% | 18/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 6.02% | -13.01% | 109.76% | 17/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 2.87% | -19.15% | -73.5% | 18/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 10.83% | -47.2% | -47.83% | 27/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 20.76% | 19.31% | 200% | 5/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 6.92% | -33.27% | 94.93% | 17/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 3.55% | -4.05% | -82.69% | 12/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 20.51% | -0.68% | 17.87% | 15/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 17.4% | -4.29% | 67.79% | 8/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 10.37% | 0.39% | 180.27% | 6/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 3.7% | -31.99% | -82.08% | 3/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 20.65% | 1.28% | 13.59% | 12/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 18.18% | 2.19% | 75.99% | 4/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 10.33% | 10.13% | 89.89% | 5/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 5.44% | 36.68% | -73.32% | 4/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 20.39% | -8.77% | 14.61% | 8/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 17.79% | -6.52% | 89.66% | 4/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 9.38% | -22.93% | 135.68% | 5/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 3.98% | 2% | -82.19% | 5/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 22.35% | -19.14% | 17.45% | 5/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 19.03% | -22.42% | 56.37% | 3/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 12.17% | -24.27% | -55.97% | 5/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2016-12-31 | 27.64% | -17.76% | 12.68% | 4/51 | 23.06% | 南华生物 | 1666.98% | 行业排名> |
| 2016-09-30 | 24.53% | 2% | 52.64% | 1/51 | 5.93% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-06-30 | 16.07% | 2% | -52.19% | 2/51 | 4.57% | 南华生物 | 383.03% | 行业排名> |
| 2015-12-31 | 33.61% | 2% | 2% | 3/51 | 22.23% | *ST宜康 | 36.84% | 行业排名> |